20 2023 lazio English-speaking jobs in Abruzzo
Senior Life Science Consultant - Senior Computer System Validation Consultant with AI Expertise
- Johnson & Johnson
- Pescara
- June 24
, 34112], [Bologna, 40100], [Bagno Di Romagna, 47021], Abruzzo, Calabria, Campania, Emilia-Romagna, Lazio
Senior Life Science Consultant - Senior Computer System Validation Consultant with AI Expertise
- Johnson & Johnson
- Montesilvano
- June 9
, 34112), (Bologna, 40100), (Bagno Di Romagna, 47021), Abruzzo, Calabria, Campania, Emilia-Romagna, Lazio
Senior Buyer
- ITT Inc. - Italian
- Alba Adriatica
- June 20
In 2023, ITT generated revenues of $3.3 billion, divided into three segments : Motion Technologies ($1.5B
Key Customer Account
- Unilever
- Pescara
- June 29
Ice Cream business, you will work for the Global, leading Ice Cream player with €7.9bn Turn Over in 2023
Contract Technician
- Eastmen Human Resources B.V.
- Pescara
- June 29
Parks, Open Spaces, and Cemeteries team participated in an external service review completed in March 2023
Sales Manager
- Ocmis Irrigazione S.p.A.
- Chieti
- June 29
Launched in October 2023, Farmfront Group is Europe’s irrigation expert and a leading global platform
Global Account Manager-Italy
- Future Electronics
- Montesilvano
- June 25
." On September 14th, 2023, it was announced that Future Electronics would join forces with WT Microelectronics
Functional Analyst
- Capgemini
- Montesilvano
- June 25
With over 55 years of heritage, 340,000 team members across more than 50 countries, and 2023 revenues
Functional Analyst
- Capgemini
- Teramo
- June 7
With over 55 years of heritage, 340,000 team members across more than 50 countries, and 2023 revenues
AI Prompt Engineer, Commercial
- Stemline Therapeutics
- Pescara
- July 1
Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority ... strong launch in February to the US market with the EMA review process concluded positively in September 2023
AI Prompt Engineer, Commercial
- Stemline Therapeutics
- Chieti
- June 29
Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority ... strong launch in February to the US market with the EMA review process concluded positively in September 2023
AI Prompt Engineer, Commercial
- Stemline Therapeutics
- Teramo
- June 28
Following a successful phase 3 study, Menarini Stemline received FDA approval in January 2023 under priority ... strong launch in February to the US market with the EMA review process concluded positively in September 2023
Senior Data Analyst
- Mews Systems
- Chieti
- June 22
and as the World's Best Independent Hotel PMS Provider 2022 and 2023 by the World Travel Tech Awards ... achievements don't stop there; Mews was also listed among the World's Best Hotel PMS Provider 2023
Product Designer, Web (Fixed-term Freelance)
- Eight Sleep
- Chieti
- June 29
Recognized as one of Fast Company's Most Innovative Companies in 2019, 2022, and 2023, and twice
Product Designer, Web (Fixed-term Freelance)
- Eight Sleep
- Teramo
- June 27
Recognized as one of Fast Company's Most Innovative Companies in 2019, 2022, and 2023, and twice
Product Designer, Web (fixed - term Freelance) Operations
- Startops
- L'Aquila
- July 1
Recognized as one of Fast Company's Most Innovative Companies in 2019, 2022, and 2023, and twice
Product Designer, Web (fixed - term Freelance) Operations
- Startops
- Pescara
- June 29
Recognized as one of Fast Company's Most Innovative Companies in 2019, 2022, and 2023, and twice
Product Designer, Web (fixed - term Freelance) Operations
- Startops
- Teramo
- June 27
Recognized as one of Fast Company's Most Innovative Companies in 2019, 2022, and 2023, and twice
Payroll Implementation Manager | Italy Deel
- Vacancies
- Teramo
- June 7
After our successful Series D in 2021, we raised another $50M in 2023, doubling our valuation to $12B
Payroll Implementation Manager | Italy Deel
- Vacancies
- L'Aquila
- June 5
After our successful Series D in 2021, we raised another $50M in 2023, doubling our valuation to $12B